Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dave Singh and Nathan Pfeifer.
Dave Singh
Connection Strength
1.208
Nathan Pfeifer
  1. Phase I study in healthy participants to evaluate safety, tolerability, and pharmacokinetics of inhaled nezulcitinib, a potential treatment for COVID-19. Clin Transl Sci. 2021 11; 14(6):2556-2565.
    View in: PubMed
    Score: 0.965
  2. A phase 2 multiple ascending dose study of the inhaled pan-JAK inhibitor nezulcitinib (TD-0903) in severe COVID-19. Eur Respir J. 2021 10; 58(4).
    View in: PubMed
    Score: 0.243
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.